7月10日，华兰生物获西南证券买入评级，近一个月华兰生物获得2份研报关注。
研报预计公司2024-2026年归母净利润分别为16.8亿元、18.7亿元、20.7亿元。公司董事长、部分董事、高管共10人拟以自有资金于未来6个月内增持公司股份，合计增持数量不低于122万股，不高于242万股。此次增持计划彰显了公司董事会成员及高管对公司长期投资价值的认可和未来发展信心。公司新浆站陆续获批开采，研报看好其未来增长潜力。
风险提示：采浆量不及预期、四价流感疫苗放量不及预期、研发进展不及预期等风险。
- Headlines
- 华兰生物获西南证券买入评级，实控人及高管拟增持公司股份
华兰生物获西南证券买入评级，实控人及高管拟增持公司股份
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
13:32
央行研究局局长王信：关键要畅通利率政策传导
13:31
Wang Xin, director of the Research Bureau of the Central Bank: Interest rate policy will adapt to changes in the situation and appropriately increase counter-cyclical adjustments at the right time.
13:29
CHINA RES BEER's Hou Xiaohai: The beer Industry is not as competitive as XINXINGCHANYE; we are orderly and harmonious.
CHINA RES BEER-5.39%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.